Cambrooke Therapeutics' Acquisition

Cambrooke Therapeutics was acquired by Ajinomoto on November 10, 2017.

Cambric Therapeutics, formerly known as Cambrooke Foods, provides medical food products for people with phenylketonuria (PKU) via the Glytactin protein source, for people with other inborn errors of p…

Articles about Cambrooke Therapeutics' Acquisition: